a16z 领投了拉美医疗 AI 平台 Telepatia 的 3300 万美元 A 轮，覆盖 1400 万患者，创始人因家庭悲剧而创业。
Telepatia 是一家面向拉丁美洲的 AI 原生临床平台，提供 AI 抄写、临床决策支持和 AI 审计功能，连接医院所有数据源。自 2025 年 7 月上线以来，已在巴西、哥伦比亚和墨西哥超过 25 家医院系统部署，覆盖 1400 万患者。本轮 3300 万美元 A 轮由 a16z 领投，总融资额达 4200 万美元。创始人 Nicolás Abad 的父亲因药物相互作用去世，推动他开发这款产品。
We're thrilled to lead Telepatia's $33M Series A. @Nicobot01's father was a physician in Colombia w...
We're thrilled to lead Telepatia's $33M Series A. @Nicobot01 's father was a physician in Colombia who died at 58 from a drug interaction AI could have flagged in seconds. Nicolás is building the product that could have saved him. Telepatia is the AI-native clinical platform for Latin America spanning an AI scribe, clinical decision support, and AI auditor, each connected to every data source across the hospital. Since launching in July 2025, the platform has deployed across 25+ hospital systems in Brazil, Colombia, and Mexico, reaching 14M patients. Welcome, Nicolás and the Telepatia team. By @daisydwolf , @GEVS94 , and @evajsteinman Nicolás Abad @Nicobot01 Telepatia has raised $42 million, including a $33 million Series A led by a16z. My father’s nickname was Telepatia. He was a doctor who passed away at 58 from a preventable cause. A few days after his death, ChatGPT launched. My first thought was that an AI Doctor would have saved his life as a patient, and that he would have loved using one as a doctor. So we built it: an AI Doctor for doctors, by doctors. Telepatia's AI Doctor is live in more than 25 public and private health institutions, home to more than 100,000 doctors and nurses throughout Latin America 🇧🇷🇨🇴🇲🇽🇨🇱🇦🇷 We're building an AI Doctor and our goal is to bring Latin America its first Nobel Prize in Medicine since 1984. Your browser does not support the video tag. 🔗 View on Twitter 🔗 View Quoted Tweet 💬 0 🔄 0 ❤️ 1 👀 415 ⚡